baber/WOPTO huggingface dataset:
Patent NZ-590457-A (NZ)
Title: Packaging assembly having a sensory interactable element
Inventor: STEPHENS JERRY RAY
IPC: G09F13/04
Filed: 2009-06-25
Abstract: 590457 Disclosed is a sensory interactable packaging assembly (10). The assembly (10) includes a base (20) with a power supply, and a container (30) for containing a consumer product (35). The container (30) is removably attachable to the base (20) and includes an outer surface, (33) and a plurality of sensory interactable elements (42) disposed on the outer surface (33) cooperatively combined to form an image (40). The assembly (10) also includes a control system with an output, is integral with the container (30) and is in electrical communication with the sensory interactable elements (42). The sensory interactable elements (42) are responsive to the output of the control system when the container (30) is in mating engagement with the base (20) and the control system is in electrical communication with the power supply. The container (30) further includes a first conductive unit in electrical communication with the power supply. The base (20) further includes a second conductive unit in electrical communication to the control system such that the first conductive unit and second conductive unit are in contact with each other when the container (30) is in mating engagement with the base (20).
Patent NZ-591236-A (NZ)
Title: Methods for determining a breeding value based on a plurality of genetic markers
Inventor: SU GUOSHENG
IPC: G16B20/20
Filed: 2009-08-19
Abstract: Disclosed is a method for determining the individual effect of a plurality of genetic marker alleles on udder health, fertility and/or other health of a plurality of reference bovine subjects. The marker effects are employed in another aspect of the invention for determining a genomic estimated breeding value of a bovine subject based on the genotype of said bovine subject by correlating its genotype with the effect of each individual genetic marker allele on udder health, fertility, other health and/or estimated breeding value of the reference bovine subjects. Further provided are methods and computer program products and computer readable media for executing the methods of the invention.
Patent NZ-594749-A (NZ)
Title: Amino alcohol solutions of n-(n-butyl)thiophosphoric triamide (nbpt) and urea fertilizers using such solutions as urease inhibitors
Inventor: WHITEHURST GARNETT BROOKS
IPC: C05C9/00
Filed: 2010-02-03
Abstract: 594749 Disclosed herein is a method of preparing a solution when used for reducing the volatility of urea fertilizers comprising dissolving N-(n-butyl)-thiophosphoric triamide (NBPT) in an amino alcohol having the formula 1 - (H)x-N-((CH2)m - OH)n where m is 1-3, x is 0 or 1, and n is 2 when x is 1 and 3 when x is 0: or the formula 2 - (H)y-N-((CH2)-CHOH-CH3)z such that the length of the carbon chain where the secondary hydroxyl group is located is 3, y is 0 or 1, and z is 2 when y is 1 and 3 when y is 0. More particularly wherein the amino alcohol is diethanolamine, dipropanolamine, triethanolamine, tripropanolamine, diisopropanolamine or triisopropanolamine. The method wherein said NBPT is dissolved in said amino alcohol and a co-solvent selected from the group consisting of ethylene glycol and propylene glycol. Additionally disclosed is a method of producing reduced volatility of urea fertilizers comprising: a) preparing an NBPT solution as described herein; and b) combining said NBPT solution with said urea fertilizer.
Patent NZ-602368-A (NZ)
Title: Iap bir domain binding compounds
Inventor: LAURENT ALAIN
IPC: C12N9/64
Filed: 2011-02-11
Abstract: Disclosed herein is compound of Formula 1 : (I) or salt thereof which binds to IAP BIR domains, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods.
Patent NZ-603635-A (NZ)
Title: Pin bone remover
Inventor: VAHAB ALI
IPC: A22C25/16
Filed: 2011-05-17
Abstract: 603635 Disclosed is a pin bone removing apparatus for removing pin bones from fish fillets. The apparatus employs a method of applying an intermittent pulling force so that pin bones remain whole upon removal from fish fillets. The apparatus comprises a drive train. The drive train includes a drive axis coupled to a motor. A rotatable cylinder head (30) is coupled to the drive axis. The cylinder head has a recessed envelope surface (31). A resilient tongue is in contact with the envelope surface (31) such that pin bones can be pinched between the tongue and the envelope surface (31) as to be pulled out from the fillet when the cylinder head (30) is rotated. The apparatus further comprises a torque limiter (52) in the drive train. Upon reaching a pre-set torque value, the rotatable cylinder head (30) will become uncoupled. A mechanism comprising at least two spring biased rotational motion transmitting elements (34) is adapted to cause intermittent pulling of pin bones. The elements (34) are fixedly coupled at one end to a first section of the drive train and realisably coupled at a second end with a second section of the drive train.
Patent NZ-613301-A (NZ)
Title: Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
Inventor: ITO MASANORI
IPC: A61K31/7034
Filed: 2012-03-07
Abstract: Provided are pharmaceutical compositions comprising metformin and a DPP-4 inhibitor and/or a SGLT-2 inhibitor. A preferred DPP-4 inhibitor is linagliptin. A preferred SGLT-2 inhibitor is 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene. The pharmaceutical composition may comprise the following: a)an inner extended release core comprising metformin (particularly metformin hydrochloride) and one or more excipients; b)an optional intermediate seal coating; and c)an outer immediate release coating comprising at least one active pharmaceutical ingredient selected from: a DPP-4 inhibitor, preferably linagliptin, and a SGLT-2 inhibitor, preferably 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, and one or more excipients. The pharmaceutical compositions may be useful in the treatment of metabolic disorders such as diabetes.
Patent NZ-616642-A (NZ)
Title: Quinazoline derivatives for the treatment of viral infections and further diseases
Inventor: RABOISSON PIERRE JEAN-MARIE BERNARD
IPC: C07D239/95
Filed: 2012-05-18
Abstract: This disclosure relates to 2,4-aminoquinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy of disorders in which the modulation of toll - like - receptors is involved, typically in the treatment of viral infections. compounds of the disclosure include: (3S)-3-[(2-amino-5-methylquinazolin-4-yl)amino]hexan-1-ol, (3S)-3-[(2-amino-6,7-dimethoxyquinazolin-4-yl)amino]hexan-1-ol, and (3S)-3-[(2-amino-8-fluoroquinazolin-4-yl)amino]hexan-1-ol
Patent NZ-618663-A (NZ)
Title: Apparatus and method for re-levelling a slab
Inventor: FABIO PARODI
IPC: E04G23/06
Filed: 2013-12-05
Abstract: 618663 A system and method for re-levelling a concrete slab (2) is disclosed. Where liquefaction or subsidence has occurred under and around the slab the end result is that the slab is no longer level, and hence the dwelling is no longer level. The system includes a slab of reinforced concrete and lifting mechanisms (15) such as hydraulic jacks. The slab has cavities (3) located in the perimeter and below the top surface. Each cavity forms an opening in the perimeter which accepts the lifting mechanism so it may bear on the underside (16) of the cavity and lift the slab. After the slab is lifted it may optionally be rested on supports so that the jacks can be removed. A new level surface (20 – Fig 7) is formed under the slab to support it using grout or similar and when it has cured the slab is lowered to rest on it. The lifting mechanisms may rest on platforms (6) tied to the slab by rebar (11) through a hole (8) to insure that they stay under each associated cavity even during lateral movement of the slab.
Patent NZ-619895-A (NZ)
Title: Method of identifying disease risk factors
Inventor: ROSES ALLEN D
IPC: G01N33/50
Filed: 2009-08-11
Abstract: Disclosed is a method of determining increased risk for development of Alzheimer’s disease in a subject, comprising: (a) detecting from a biological sample containing DNA taken from said subject the presence of a genetic variant of the TOMM40 gene associated with increased risk of Alzheimer’s disease, wherein said variant is a poly-T deletion/insertion polymorphism (DIP) at rsl0524523 in intron 6 of the TOMM40 gene, and wherein the poly-T DIP has a poly-T length of about 21 to about 29 T residues; and (b) determining said subject is at increased risk of Alzheimer’s disease when said genetic variant is present. Further disclosed is the use of an anti-Alzheimer’s disease active agent in the manufacture of a medicament for treating Alzheimer’s disease wherein the medicament is adapted for administration to a subject at an earlier age when said subject carries a genetic variant of the TOMM40 gene associated with increased risk of Alzheimer’s disease as compared to a corresponding subject who does not carry said genetic variant, wherein said genetic variant of the TOMM40 is a poly-T deletion/insertion polymorphism (DIP) at rs10524523 in intron 6 of the TOMM40 gene, and wherein the poly-T DIP has a poly-T length of about 21 to about 29 T residues.
Patent NZ-621345-A (NZ)
Title: Methods of treatment of retinal degeneration diseases
Inventor: COSMA MARIA PIA
IPC: A61K35/20
Filed: 2012-08-06
Abstract: Discloses use of a mesenchymal stem cell (MSC) or a cell population comprising a hematopoietic stem cell (HSC) and a progenitor cell, wherein the Wnt/β-catenin signalling pathway of said cells is activated, in the manufacture of a medicament for the treatment of a retinal degeneration disease by direct implantation of said cells into the eye of a subject in need of treatment. Also discloses a cell composition, wherein at least 50% of the cells of said cell composition are hematopoietic stem cells (HSCs) and progenitor cells and wherein the Wnt/β-catenin signalling pathway of said cells is activated.
Patent NZ-626334-A (NZ)
Title: Photoactivated chemical bleaching of dyes
Inventor: NATARAJAN ARUNKUMAR
IPC: G01N33/48
Filed: 2012-12-03
Abstract: Methods comprising the use of photoactivated chemical bleaching for detecting multiple targets in a biological sample are provided. The methods include the steps of providing a biological sample including multiple targets, binding at least one probe to one or more target present in the sample, and observing a signal from the probe. The method further includes the steps of contacting the sample comprising the bound probe with an electron transfer reagent and irradiating the sample, thereby initiating a photoreaction that substantially inactivates the probe by photoactivated chemical bleaching. The method further includes the steps of binding at least one probe to one or more target present in the sample, and observing a signal from the probe. The process of binding, observing and bleaching may be iteratively repeated.
Patent NZ-628989-A (NZ)
Title: Synthetic chloroplast transit peptides
Inventor: ROBINSON ANDREW E
IPC: C12N15/82
Filed: 2013-02-01
Abstract: Disclosed is an isolated nucleic acid molecule comprising: a nucleotide sequence that encodes a synthetic chloroplast transit peptide (CTP) consisting of an amino acid sequence that is derived from an alignment of the amino acid residues of 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) enzymes; and a nucleotide sequence of interest encoding a peptide of interest operably linked to the synthetic CTP-encoding nucleotide sequence, wherein the nucleic acid molecule encodes a chimeric polypeptide comprising a peptide encoded by the nucleotide sequence of interest and the synthetic CTP, and wherein the peptide encoded by the nucleotide sequence of interest is targeted to a plastid in a plastid-containing cell
Patent NZ-630695-A (NZ)
Title: Nasal mask system
Inventor: GUNEY MEMDUH
IPC: A62B18/08
Filed: 2013-04-12
Abstract: A swivel elbow and connector assembly for a patient interface system includes a ring (128) configured to be sealingly secured in an aperture of the patient interface system and an elbow (125) swivably secured in the ring. The ring includes a first side in an interior of the patient interface system and a second side at an exterior of the patient interface system when the ring is secured in the aperture. The ring comprises a first flange on the first side and a second flange on the second side, the first and second flanges defining a channel that sealingly engages the aperture of the patient interface system. An inner surface of the ring is partially spherical and an outer surface of the elbow is partially spherical and the elbow and the ring form a ball and socket connection. The assembly includes a decoupling system having multiple decoupling structures (a decoupling gusset (158(1)), the ball and socket joint provided by the elbow and ring, and a swivel cuff (129)) to permit decoupling of tube torque and/or tube drag forces from the sealing forces applied by the cushion assembly (250) to the patient’s face.
Patent NZ-700672-A (NZ)
Title: Telecommunications enclosure and organizer
Inventor: AZNAG MOHAMED
IPC: H02G3/08
Filed: 2013-03-21
Abstract: A closure (10) includes a cover (4) and seal block (18). A feeder cable pathway and rear cover is provided for separation of feeder cables from drop cables. The organizer (426) in the closure includes an end cap and rear cable storage (190). Cable fixation clips, linear or bendable, can be used individually or daisy chained together. Cable fixation chambers (224, 226) are positioned on top of the gel block (220) housing. The organizer is a click together organizer. Dual heights on cable guides on sides of the groove plate facilitate cable installation. Tray supports with rounded ends prevent looseness of the tray mounts. Other organizers include cable routing features for compact storage.
Patent NZ-701047-A (NZ)
Title: High pressure resistant safety shield for a pipe joint
Inventor: DAVID GOODING
IPC: F16L55/168
Filed: 2014-10-15
Abstract: The present invention relates to a high pressure resistant safety shield for a pipe joint carrying a pressurised fluid or gas. Problems of prior art safety shields include that they are not able to withstand pressures higher than nominal pump transmission pressures, as they do not allow the pressure to dissipate and do not have a central pressure restraining strap. In addition to this, the construction of prior art safety shields is highly specialized and technically complex. Another disadvantage of the prior art safety shields is that they are relatively expensive. The present invention seeks to solve these problems by providing a safety shield comprising a pliable body which is able to withstand hydraulic pressures exceeding 10,000 psi (68,947.573 kPa) and absorb a fluid or gas burst failure up to 69,000 kN/m2. Specifically, the present invention comprises a shield (1) for a pipe joint carrying a pressurized fluid or gas, comprising a closeable or sealable pliable body (2) of a length and a width to be wrapped around the pipe joint, wherein the width is larger in the middle of the pliable body than at its end parts (2a) and (2b) and at least three sealing or closing means (3) located on central and end parts of the body (2), characterized in that the closeable or sealable pliable body (2) comprises an inner layer (4) made of woven material to withstand high impact forces, an outer layer (8) made of polymer coated glass cloth, the outer layer (8) located on at least the central part of the body (2), at least two intermediate parts (7) made of a macromolecular material located between the central part and the end parts of the body (2) and an intermediate layer of stainless steel located in the central part of the body (2).
Patent NZ-710773-A (NZ)
Title: Cheese anticake for enhanced melt
Inventor: LEVINE BRIAN E
IPC: A23C19/16
Filed: 2014-03-05
Abstract: Particulate natural cheese products having a modified starch composition as an anticaking agent as well as methods of melting the shredded cheese product are provided. The modified starch anticaking agent provides intact starch granules including amylopectin and substantially no amylose for the particulate cheese. During heating, the natural cheese melt is resistant to separation, and retains desirable organoleptic properties such as texture and flavor in the final product.
Patent NZ-724488-A (NZ)
Title: Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
Inventor: DOKOU ELENI
IPC: A61K45/06
Filed: 2015-04-14
Abstract: The present invention features pharmaceutical compositions comprising a spray dried dispersion of amorphous (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropane carboxamide (Compound 1) and a spray dried dispersion of amorphous N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 2), useful for the treatment of cystic fibrosis.
Patent NZ-727954-A (NZ)
Title: Light-emitting helmet and manufacturing method thereof
Inventor: ZHIMING LI
IPC: F21V21/084
Filed: 2016-12-23
Abstract: A light-emitting helmet and a manufacturing method thereof are provided. The helmet includes a main body, a plurality of fixing frames and a plurality of lamp strips. The main body includes a plurality of grooves on its outer surface. The fixing frames are located under the grooves and used for mounting the lamp strips. The lamp strips are configured to be detachably mounted to the grooves from the outer surface of the main body through the engagement with the fixing frames. The lamp strips and the main body of the helmet may be separately maintained. In the manufacturing method of the helmet, the lamp strips and the main body are manufactured separately and then assembled to avoid a damage of the lamp strips due to a high pressure or a high temperature during a manufacturing process of the helmet.
Patent NZ-731208-A (NZ)
Title: Contamination preventive glove donning device
Inventor: PHILIP-LING CHANG
IPC: A61B42/50
Filed: 2017-04-20
Abstract: A contamination preventive glove donning device provides assisted quick release of the gloves after donning, and helps to reduce contamination of the gloves during the donning procedure. The device includes a support member set (1), two barrels (2) held in parallel by the support member set (1), each barrel (2) including a barrel body (21), a coupling neck (22) axially extended from the barrel body (21) for holding the wrist (61) of one of a pair of rubber gloves (6), a chamber (23) defined in the coupling neck (22) and the barrel body (21) that is enclosed when the user attach the wrists (61) of a pair of rubber gloves (6) onto the coupling necks (22) of the barrels (2) and a guide groove (223) located on the coupling neck (22) and extended in direction away from the barrel body (21), and a vacuum generator (3) adapted for creating a negative pressure in the chamber (23) in each barrel (2) for enabling the attached rubber gloves (6) to be expanded for donning, preve while protecting the chambers (23) of the barrels (2) against outside air pollutions.
Patent NZ-747390-A (NZ)
Title: Peptide with anti-obesity and anti-diabetes activity and use thereof
Inventor: CHUNG YONG JI
IPC: A61K38/08
Filed: 2015-05-12
Abstract: A peptide and a peptide complex of the present invention exhibit an anti-obesity effect by inhibiting fat accumulation and decomposing already accumulated fat, and exhibit an excellent effect with respect to diabetes by effectively reducing blood sugar. The peptide and the peptide complex of the present invention decrease the expression of PPARγ, ACC, and aP2, which are adipogenic markers, increase the expression of pHSL, AMPK-α1, CGI-58, and ATGL, which are lipolytic factors, and reduce the size of fat cells and blood cholesterol values. The peptide and the peptide complex of the present invention, which have excellent activity and safety, can be advantageously applied to drugs and quasi-drugs.
Patent NZ-773473-A (NZ)
Title: N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors
Inventor: GERSTENBERGER BRIAN STEPHEN
IPC: A61P37/00
Filed: 2019-09-18
Abstract: The present invention relates to N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamide compounds of Formulae (IA and 1B) or a pharmaceutically acceptable salt or hydrate thereof, that inhibit CC chemokine receptor 6 (CCR6), pharmaceutical compositions containing these compounds, and the use of these compounds for treating or preventing diseases, conditions, or disorders ameliorated by inhibition of CCR6.
Patent NZ-776195-A (NZ)
Title: Bioreactors for growing micro-organisms
Inventor: PITKÄNEN JUHA-PEKKA
IPC: C12M1/00
Filed: 2019-12-20
Abstract: The present invention seeks to provide a solution to the existing problem of low dissolution and short residence time of gases in reaction mixture inside a bioreactor by providing a bioreactor (100) for growing micro-organisms, comprising a reaction chamber (102) and a draft tube (210) arranged inside the reaction chamber, which draft tube has at least one gas inlet (104, 106, 108), an inlet for the reaction mixture at its first end, and an outlet for the reaction mixture at its second end. The bioreactor also comprises means for generating flow (224) of the reaction mixture within the reaction chamber and at least a first blade structure (226A, 226B) arranged inside the reaction chamber, surrounding the draft tube.
Patent PT-100771-A (PT)
Inventor: DESMARAIS THOMAS ALLEN
IPC: C08J/
Filed: 1992-08-12
Abstract: Normally hydrophobic foams, such as polyurethane foams and polymerized water-in-oil emulsion foams, are rendered hydrophilic by means of treatment with simple surfactants and hydrophilizing agent salts. Thus, a surfactant-containing foam is treated with a solution of, for example, calcium chloride, and is dried to leave a substantially uniformly distributed residue of hydrated or hydratable calcium chloride on the surfactant-containing internal foam surfaces. In-use, the combination of surfactant and calcium chloride hydrate provides a hydrophilic surface to the foam. Other hydratable calcium or magnesium salts such as magnesium chloride can be used. The resulting hydrophilized foams are suitable for use in absorbent devices, including diapers, sanitary napkins, bandages, and the like.
Patent PT-101092-A (PT)
Inventor: BLANK ROY LONNIE
IPC: A61K8/00
Filed: 1992-11-25
Abstract: The present invention relates to the use of a cosmetic composition comprising a safe and effective amount of a sunscreening agent and a safe and effective amount of salicylic acid for regulating wrinkles and/or atrophy in mammalian skin.
Patent PT-104167-A (PT)
Title: Máquina de ensaios de hopkinson por impulsão electromagnética
Inventor: MARTINS PAULO ANTONIO FIRME
IPC: G01N3/317
Filed: 2008-09-03
Abstract: O PRESENTE INVENTO REFERE-SE A UMA ALTERAÇÃO DA MÁQUINA DE ENSAIOS DE HOPKINSON POR INTRODUÇÃO DE UM SISTEMA DE IMPULSÃO ELECTROMAGNÉTICA, EM SUBSTITUIÇÃO DOS SISTEMAS TÍPICOS DE IMPULSÃO PNEUMÁTICA. ESTE INVENTO É ESPECIALMENTE INDICADO EM APLICAÇÕES DA MÁQUINA DE ENSAIOS DE HOPKINSON ONDE SE PRETENDA UMA DIMENSÃO GLOBAL MAIS REDUZIDA DO EQUIPAMENTO, PERMITINDO AINDA UM MELHOR DESEMPENHO EM TERMOS DA VELOCIDADE MÁXIMA ALCANÇÁVEL, DO AJUSTE E REPETIBILIDADE DOS RESULTADOS, E NA MINIMIZAÇÃO DA PROPAGAÇÃO DE RUÍDOS PARASITA (TÍPICOS DA ABERTURA DAS VÁLVULAS PNEUMÁTICAS, DA EXPANSÃO DOS GÁS E DO ROÇAMENTO DA BARRA PROJÉCTIL NO SISTEMA DE DISPARO). A MÁQUINA PROPOSTA RESUME-SE À INCORPORAÇÃO DE UM ACTUADOR/DISPARADOR ELECTROMAGNÉTICO (3) NUMA ESTRUTURA DE UMA BARRA DE HOPKINSON (1) , COM O INTUITO DE SUBSTITUIR OS TRADICIONAIS DISPARADORES DE AR COMPRIMIDO. ATRAVÉS DE UMA BANCO DE POTÊNCIA (2) É POSSÍVEL EFECTUAR A DESCARGA ELÉCTRICA, A QUAL FARÁ COM QUE O ACTUADOR ELECTROMAGNÉTICO TRANSMITA MOVIMENTO À BARRA PROJÉCTIL (4).